Deep Learning-Assisted Quantitative Susceptibility Mapping as a Tool for Grading and Molecular Subtyping of Gliomas.

IF 3.7 Q2 GENETICS & HEREDITY
Phenomics (Cham, Switzerland) Pub Date : 2023-01-05 eCollection Date: 2023-06-01 DOI:10.1007/s43657-022-00087-6
Wenting Rui, Shengjie Zhang, Huidong Shi, Yaru Sheng, Fengping Zhu, YiDi Yao, Xiang Chen, Haixia Cheng, Yong Zhang, Ababikere Aili, Zhenwei Yao, Xiao-Yong Zhang, Yan Ren
{"title":"Deep Learning-Assisted Quantitative Susceptibility Mapping as a Tool for Grading and Molecular Subtyping of Gliomas.","authors":"Wenting Rui, Shengjie Zhang, Huidong Shi, Yaru Sheng, Fengping Zhu, YiDi Yao, Xiang Chen, Haixia Cheng, Yong Zhang, Ababikere Aili, Zhenwei Yao, Xiao-Yong Zhang, Yan Ren","doi":"10.1007/s43657-022-00087-6","DOIUrl":null,"url":null,"abstract":"<p><p>This study aimed to explore the value of deep learning (DL)-assisted quantitative susceptibility mapping (QSM) in glioma grading and molecular subtyping. Forty-two patients with gliomas, who underwent preoperative T2 fluid-attenuated inversion recovery (T2 FLAIR), contrast-enhanced T1-weighted imaging (T1WI + C), and QSM scanning at 3.0T magnetic resonance imaging (MRI) were included in this study. Histopathology and immunohistochemistry staining were used to determine glioma grades, and <i>isocitrate dehydrogenase</i> (<i>IDH</i>) <i>1 </i>and <i>alpha thalassemia/mental retardation syndrome X-linked gene</i> (<i>ATRX</i>) subtypes. Tumor segmentation was performed manually using Insight Toolkit-SNAP program (www.itksnap.org). An inception convolutional neural network (CNN) with a subsequent linear layer was employed as the training encoder to capture multi-scale features from MRI slices. Fivefold cross-validation was utilized as the training strategy (seven samples for each fold), and the ratio of sample size of the training, validation, and test dataset was 4:1:1. The performance was evaluated by the accuracy and area under the curve (AUC). With the inception CNN, single modal of QSM showed better performance in differentiating glioblastomas (GBM) and other grade gliomas (OGG, grade II-III), and predicting <i>IDH1</i> mutation and <i>ATRX</i> loss (accuracy: 0.80, 0.77, 0.60) than either T2 FLAIR (0.69, 0.57, 0.54) or T1WI + C (0.74, 0.57, 0.46). When combining three modalities, compared with any single modality, the best AUC/accuracy/F1-scores were reached in grading gliomas (OGG and GBM: 0.91/0.89/0.87, low-grade and high-grade gliomas: 0.83/0.86/0.81), predicting <i>IDH1</i> mutation (0.88/0.89/0.85), and predicting <i>ATRX</i> loss (0.78/0.71/0.67). As a supplement to conventional MRI, DL-assisted QSM is a promising molecular imaging method to evaluate glioma grades, <i>IDH1</i> mutation, and <i>ATRX</i> loss.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s43657-022-00087-6.</p>","PeriodicalId":74435,"journal":{"name":"Phenomics (Cham, Switzerland)","volume":"3 3","pages":"243-254"},"PeriodicalIF":3.7000,"publicationDate":"2023-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10260708/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phenomics (Cham, Switzerland)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s43657-022-00087-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to explore the value of deep learning (DL)-assisted quantitative susceptibility mapping (QSM) in glioma grading and molecular subtyping. Forty-two patients with gliomas, who underwent preoperative T2 fluid-attenuated inversion recovery (T2 FLAIR), contrast-enhanced T1-weighted imaging (T1WI + C), and QSM scanning at 3.0T magnetic resonance imaging (MRI) were included in this study. Histopathology and immunohistochemistry staining were used to determine glioma grades, and isocitrate dehydrogenase (IDH) and alpha thalassemia/mental retardation syndrome X-linked gene (ATRX) subtypes. Tumor segmentation was performed manually using Insight Toolkit-SNAP program (www.itksnap.org). An inception convolutional neural network (CNN) with a subsequent linear layer was employed as the training encoder to capture multi-scale features from MRI slices. Fivefold cross-validation was utilized as the training strategy (seven samples for each fold), and the ratio of sample size of the training, validation, and test dataset was 4:1:1. The performance was evaluated by the accuracy and area under the curve (AUC). With the inception CNN, single modal of QSM showed better performance in differentiating glioblastomas (GBM) and other grade gliomas (OGG, grade II-III), and predicting IDH1 mutation and ATRX loss (accuracy: 0.80, 0.77, 0.60) than either T2 FLAIR (0.69, 0.57, 0.54) or T1WI + C (0.74, 0.57, 0.46). When combining three modalities, compared with any single modality, the best AUC/accuracy/F1-scores were reached in grading gliomas (OGG and GBM: 0.91/0.89/0.87, low-grade and high-grade gliomas: 0.83/0.86/0.81), predicting IDH1 mutation (0.88/0.89/0.85), and predicting ATRX loss (0.78/0.71/0.67). As a supplement to conventional MRI, DL-assisted QSM is a promising molecular imaging method to evaluate glioma grades, IDH1 mutation, and ATRX loss.

Supplementary information: The online version contains supplementary material available at 10.1007/s43657-022-00087-6.

深度学习辅助定量易感性图谱作为胶质瘤分级和分子亚型的工具。
本研究旨在探讨深度学习(DL)辅助的定量易感性图谱(QSM)在神经胶质瘤分级和分子分型中的价值。42例胶质瘤患者,术前接受T2液体衰减倒置恢复(T2 FLAIR)、对比增强T1加权成像(T1WI) + C) 和3.0T磁共振成像(MRI)下的QSM扫描。组织病理学和免疫组织化学染色用于确定神经胶质瘤分级,以及异柠檬酸脱氢酶(IDH)1和α-地中海贫血/智力迟钝综合征X连锁基因(ATRX)亚型。使用Insight Toolkit SNAP程序(www.itksnap.org)手动进行肿瘤分割。使用具有后续线性层的初始卷积神经网络(CNN)作为训练编码器,从MRI切片中捕获多尺度特征。五次交叉验证被用作训练策略(每次七个样本),训练、验证和测试数据集的样本量之比为4:1:1。通过准确度和曲线下面积(AUC)来评估性能。与T2 FLAIR(0.69,0.57,0.54)或T1WI相比,在开始CNN时,单一模式的QSM在区分胶质母细胞瘤(GBM)和其他级别的胶质瘤(OGG,II-III级)以及预测IDH1突变和ATRX损失(准确度:0.80,0.77,0.60)方面表现出更好的性能 + C(0.74,0.57,0.46)。当将三种模式组合时,与任何单一模式相比,在胶质瘤分级(OGG和GBM:0.91/0.89/0.87,低级别和高级别胶质瘤:0.83/0.86/0.81)、预测IDH1突变(0.88/0.89/0.85)和预测ATRX损失(0.78/0.71/0.67)方面达到了最佳AUC/准确性/F1评分。作为常规MRI的补充,DL辅助的QSM是一种很有前途的分子成像方法,用于评估神经胶质瘤分级、IDH1突变和ATRX损失。补充信息:在线版本包含补充材料,请访问10.1007/s43657-022-00087-6。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信